Vertex Pharmaceuticals (VRTX) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist

459.000
-3.580-0.77%

Close Feb 14 16:00 ET

459.000
0.0000.00%

Post 20:01 ET

117.87BMarket Cap-220.67P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

CRISPR Upped to Outperform by Evercore on Upcoming Data
Seeking AlphaFeb 14 10:55 ET
Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing
Yahoo FinanceFeb 14 04:35 ET
Express News | Vertex Pharmaceuticals Inc Files for Mixed Shelf; Size Not Disclosed - SEC Filing
ReutersFeb 13 17:14 ET
Wall Street Today: Trump Assigns Tariff Homework Study, Market Climbs
Kevin TraversFeb 13 16:20 ET
Vertex Pharmaceuticals | 10-K: FY2024 Annual Report
SECFeb 13 16:06 ET · Announcements
Live Stock News: Tariffs are so Back While Stocks Climb
Kevin TraversFeb 13 11:27 ET

Comments

Teddy123

Jan 31 01:16

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England

$Vertex Pharmaceuticals (VRTX.US)$
Revolutionary Gene Therapy CASGEVY Now Available Through NHS England: Major Win for Sickle Cell Patients

Teddy123

Jan 30 23:42

Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain

$Vertex Pharmaceuticals (VRTX.US)$
FDA Approves First Non-Opioid Pain Drug in 20 Years: Vertex's Game-Changing Alternative to Opioids

Stock_Drift

Jan 30 19:13

$Vertex Pharmaceuticals (VRTX.US)$

Vertex Pharmaceuticals Jumps On FDA Approval For Non-Opioid Painkiller

Lnova

Jan 28 03:25

$Vertex Pharmaceuticals (VRTX.US)$ am watching this one to see the outcome biopharmcatalys...
has options
“Suzetrigine: The FDA has assigned a PDUFA target action date of January 30, 2025, for suzetrigine for the treatment of moderate-to-severe acute pain. Suzetrigine was granted Priority Review by the FDA.
The Non-Opioids Prevent Addiction In the Nation (NOPAIN) Act became effective on January 1st, 2025. The NOPAIN Act mandates that Medicare provide a separate add-on payment in the hospital outp...

101721316

Dec 29, 2024 04:21

$Vertex Pharmaceuticals (VRTX.US)$ long term play

VRTX Vertex Pharmaceuticals

Trade Overview

Capital Trend

News

Comments

Trending Stocks